{
    "organizations": [],
    "uuid": "b5fa7b6bcd26b0c411305346a4b45e0e292bf839",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tocagen-estimates-cash-cash-equiva/brief-tocagen-estimates-cash-cash-equivalents-and-marketable-securities-about-89-0-million-as-of-dec-31-2017-idUSFWN1P30ID",
    "ord_in_thread": 0,
    "title": "BRIEF-Tocagen Estimates Cash, Cash Equivalents And Marketable Securities About $89.0 Million As Of Dec 31, 2017",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Tocagen Inc:\n* TOCAGEN SAYS ESTIMATE CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE ABOUT $89.0 MILLION AS OF DEC 31, 2017 - SEC FILING\n* TOCAGEN - ESTIMATE TOTAL CASH USED IN 2018 TO FUND OPERATIONS, CAPITAL EXPENDITURES, DEBT AMORTIZATION TO NOT EXCEED $50.0 MILLION Source text ( bit.ly/2FcFCph ) Further company coverage:\n ",
    "published": "2018-01-08T19:40:00.000+02:00",
    "crawled": "2018-01-09T17:01:44.019+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "tocagen",
        "inc",
        "tocagen",
        "say",
        "estimate",
        "cash",
        "cash",
        "equivalent",
        "marketable",
        "security",
        "million",
        "dec",
        "sec",
        "filing",
        "tocagen",
        "estimate",
        "total",
        "cash",
        "used",
        "fund",
        "operation",
        "capital",
        "expenditure",
        "debt",
        "amortization",
        "exceed",
        "million",
        "source",
        "text",
        "company",
        "coverage"
    ]
}